Illicit drug use, depression and their association with highly active antiretroviral therapy in HIV-positive women
- PMID: 17291696
- PMCID: PMC4009351
- DOI: 10.1016/j.drugalcdep.2006.12.002
Illicit drug use, depression and their association with highly active antiretroviral therapy in HIV-positive women
Abstract
Background: We examined the interaction of illicit drug use and depressive symptoms, and how they affect the subsequent likelihood of highly active antiretroviral therapy (HAART) use among women with HIV/AIDS.
Methods: Subjects included 1710 HIV-positive women recruited from six sites in the U.S. including Brooklyn, Bronx, Chicago, Los Angeles, San Francisco/Bay Area, and Washington, DC. Cases of probable depression were identified using depressive symptom scores on the Center for Epidemiologic Studies Depression Scale. Crack, cocaine, heroin, and amphetamine use were self-reported at 6-month time intervals. We conducted multivariate random logistic regression analysis of data collected during 16 waves of semiannual interviews conducted from April 1996 through March 2004.
Results: We found an interaction effect between illicit drug use and depression that acted to suppress subsequent HAART use, controlling for virologic and immunologic indicators, socio-demographic variables, time, and study site.
Conclusions: This is the first study to document the interactive effects of drug use and depressive symptoms on reduced likelihood of HAART use in a national cohort of women. Since evidence-based behavioral health and antiretroviral therapies for each of these three conditions are now available, comprehensive HIV treatment is an achievable public health goal.
Figures
References
-
- Abas MA, Phillips C, Carter J, Walter J, Banerjee S, Levy R. Culturally sensitive validation of screening questionnaires for depression in older African-Caribbean people living in south London. Br J Psychiatry. 1998;173:249–254. - PubMed
-
- Ahdieh-Grant L, Tarwater PM, Schneider MF, Anastos K, Cohen M, Khalsa A, Minkoff H, Young M, Greenblatt R. Factors and temporal trends associated with highly active antiretroviral therapy discontinuation in the Women's Interagency HIV Study. J Acquir Immune Defic Syndr. 2005;38:500–503. - PubMed
-
- Anderson KH, Mitchell JM. Differential access in the receipt of antiretroviral drugs for the treatment of AIDS and its implications for survival. Arch Intern Med. 2000;160:3114–3120. - PubMed
-
- Bogart LM, Kelly JA, Catz SL, Sosman JM. Impact of medical and nonmedical factors on physician decision making for HIV/AIDS antiretroviral treatment. J Acquir Immune Defic Syndr. 2000;23:396–404. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- U01-AI-42590/AI/NIAID NIH HHS/United States
- U01 AI031834/AI/NIAID NIH HHS/United States
- U01 AI035004/AI/NIAID NIH HHS/United States
- U01-HD-32632/HD/NICHD NIH HHS/United States
- U01-AI-34994/AI/NIAID NIH HHS/United States
- U01-AI-35004/AI/NIAID NIH HHS/United States
- U01-AI-31834/AI/NIAID NIH HHS/United States
- M01-RR-00079/RR/NCRR NIH HHS/United States
- U01 AI034994/AI/NIAID NIH HHS/United States
- U01-AI-34993/AI/NIAID NIH HHS/United States
- U01 AI034989/AI/NIAID NIH HHS/United States
- M01-RR-00083/RR/NCRR NIH HHS/United States
- M01-RR-00071/RR/NCRR NIH HHS/United States
- U01 AI034993/AI/NIAID NIH HHS/United States
- U01-AI-34989/AI/NIAID NIH HHS/United States
- U01 HD032632/HD/NICHD NIH HHS/United States
- U01 AI042590/AI/NIAID NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
